Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Quinone oxidoreductases are a family of flavoprotein enzymes that catalyze the reduction of quinones to hydroquinones, using electron donors such as NADH or NADPH. These enzymes play crucial roles in cellular defense against oxidative stress and detoxification of xenobiotics. The most studied members in mammals are NAD(P)H:quinone oxidoreductase 1 (NQO1) and NQO2.
Inhibition of quinone reductase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Quinone Oxidoreductase (NQO).